Table 3.
The results of the differential methylation region analysis
| Chr | MTinnitus | MNoTinnitus | Change (%) | Gain/loss | Adj p (FDR) | Genes | Gene distance |
|---|---|---|---|---|---|---|---|
| chr6 | 2.08 | 2.58 | 19.4 | Loss | 0.0018 | HLA-DPB2 | Within DMR* |
| chr1 | − 0.43 | 0.15 | 373.8 | Loss | 0.0026 | PM20D1 | Within DMR |
| chr2 | 1.31 | 2.03 | 35.4 | Loss | 0.0040 | TMEM18, SNTG2 | 238,432, 3734 |
| chr3 | 0.76 | 1.37 | 44.0 | Loss | 0.0065 | MUC4 | Within DMR* |
| chr2 | − 3.69 | − 4.19 | 11.9 | Gain | 0.0066 | LCLAT1 | Within DMR |
| chr5 | − 1.41 | − 1.10 | 28.3 | Loss | 0.0096 | miR886 | Within DMR |
| chr8 | − 4.15 | − 3.76 | 10.3 | Loss | 0.0102 | miR596 | Within DMR |
| chr12 | − 3.49 | − 3.13 | 11.4 | Loss | 0.0117 | TXNRD1, EID3 | Within DMR |
| chr21 | − 2.04 | − 2.43 | 15.9 | Gain | 0.0127 | RUNX1 | Within DMR |
| chr5 | − 3.65 | − 3.14 | 16 | Loss | 0.0139 | SDHAP3 | Within DMR |
| chr5 | − 3.17 | − 3.49 | 9.3 | Gain | 0.0150 | RUFY1 | Within DMR |
| chr5 | − 3.61 | − 4.05 | 10.9 | Gain | 0.0170 | NUDT12 | Within DMR |
| chr15 | − 4.12 | − 4.49 | 8.2 | Gain | 0.0190 | TTC23 | Within DMR |
| chr6 | 1.57 | 1.88 | 16.6 | Loss | 0.0217 | HLA-DPB2 | Within DMR* |
| chr15 | 1.10 | 1.51 | 27.0 | Loss | 0.0235 | LASS3 (CERS3) | Within DMR |
| chr17 | − 0.40 | − 0.84 | 52.3 | Gain | 0.0249 | SLC43A2 | Within DMR |
| chr10 | 1.40 | 1.91 | 26.9 | Loss | 0.0273 | C10orf11 (LRMDA) | Within DMR |
| chr6 | − 3.57 | − 3.29 | 8.7 | Loss | 0.0335 | HLA-DQB1 | Within DMR* |
| chr1 | 3.27 | 3.83 | 14.5 | Loss | 0.0348 | NADK | Within DMR |
| chr4 | − 4.78 | − 5.09 | 6.1 | Gain | 0.0381 | C4orf37 (STPG2) | Within DMR |
| chr1 | − 2.73 | − 2.23 | 22.4 | Loss | 0.0391 | SZRD1, MFAP2 | 6045, 12 |
| chr1 | 1.84 | 2.31 | 20.5 | Loss | 0.0424 | NUP210L, TPM3 | Within DMR |
| chr8 | − 5.66 | − 5.25 | 7.8 | Loss | 0.0425 | INTS9 | Within DMR |
| chr12 | − 5.04 | − 5.60 | 10.0 | Gain | 0.0474 | EFCAB4B | Within DMR |
| chr12 | − 3.84 | − 3.49 | 9.7 | Loss | 0.0474 | SLC2A14 | Within DMR |
*DMR within the region typically not included in the genome-wide association studies. These associations are at a high risk of being false-positive hits (see Supplementary File S1)
MTinnitus and MNoTinnitus present average M-values for CpG probes within DMRs for tinnitus and no tinnitus groups, respectively. Gain (or hypermethylation) was defined as an average M-value higher (more positive) for the tinnitus group than no tinnitus group. Loss (or hypomethylation) was defined as an average M-value lower (less positive) for the tinnitus group than no tinnitus group